News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Daily News Payment Parity for Telehealth Linked to Better BP Treatment Michael O'Riordan August 07, 2024
News Daily News Private Equity Interest in Cardiology Has Spiked in Recent Years Todd Neale July 03, 2024
News Daily News AHA Kicks Off Funding for Women’s Heart Health Amid Sex Gaps Caitlin E. Cox July 01, 2024
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Daily News Plastic Debris Found in Carotid Plaque Linked to More Adverse CV Events L.A. McKeown March 06, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2024 Shelley Wood March 01, 2024
News Daily News Experts Warn of Looming Private Equity Interest in Cardiology Care Michael O'Riordan January 15, 2024
News Daily News AHA Marks 100 Years: ‘We Truly Stand on the Shoulders of Giants’ L.A. McKeown January 08, 2024
News Daily News Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients L.A. McKeown January 02, 2024
News Daily News Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden Caitlin E. Cox December 12, 2023
News Daily News Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes L.A. McKeown December 08, 2023
News Daily News Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People Todd Neale November 22, 2023
News Conference News AHA 2023 NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear L.A. McKeown November 12, 2023
News Daily News Cardiology Society Leaders Expand on Vision for New Medical Board Todd Neale October 05, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023
News Daily News ESH Upgrades Denervation, Details Comorbidities in New Hypertension Guideline Todd Neale June 27, 2023
News Daily News Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes Michael O'Riordan June 23, 2023